What a Screening Test Can — and Cannot — Tell You
Screening looks for a higher chance of a condition in people who feel well. What a result means, what it cannot settle, and three terms worth knowing.
On this page
Key points
- Screening sorts people into higher and lower chance; it usually does not give a diagnosis.
- A clear result lowers concern for now but does not rule out future illness; report symptoms anyway.
- False positives, false negatives and overdiagnosis are known limits of screening.
- Programmes differ by country; the choice to take part is yours, ideally after asking questions.
A screening test is offered to people who feel well. That makes it different from a test ordered because of a symptom, and it changes what the result means. Knowing what screening is designed to do, and what it was never designed to do, makes both an invitation letter and a result letter easier to read.
What screening is
The UK National Screening Committee describes screening as a way of identifying apparently healthy people who may have a higher chance of a disease or condition, so that they can be offered information, further tests and treatment. It uses the image of a sieve: most people pass straight through, and those left in the sieve are offered further investigation.
The World Health Organization’s guide to screening programmes gives the purpose at population level: to reduce how often a health problem occurs, or how many people die from it, by offering early treatment or intervention.
Screening programmes are national. Which tests are offered, to whom, from what age and how often varies between countries, and can differ within one country. In England, for example, the NHS offers different tests to different groups according to who is most likely to benefit. Check what your own health service offers and when.
Can and cannot, side by side
| A screening test can… | A screening test cannot… |
|---|---|
| Show that your chance of a condition is higher or lower than expected | Give a diagnosis by itself; further tests are usually needed |
| Find some problems early, before symptoms appear | Find every case |
| Lead to earlier treatment, which may be more effective | Promise that finding something early will change the outcome |
| Give reassurance about your risk at present | Rule out the condition developing later |
| Reduce deaths from some conditions across a population | Tell one individual in advance whether they will be the person who benefits |
Each line of the table rests on published guidance. The NHS in England says screening can detect a problem early, when treatment may be more effective, and that some deaths from certain conditions can be prevented. The UK National Screening Committee says plainly that screening does not guarantee protection, and that a low-chance result does not prevent a person from developing the condition later. The US National Cancer Institute (NCI) notes that an abnormal screening result usually leads to diagnostic tests to find out whether disease is really present. It adds that being offered screening does not mean a doctor thinks you are ill.
Three terms worth knowing
False positive
A positive screening result in someone who does not have the condition. The NHS describes the effect: you could be told you have a problem when you do not, which can lead to further tests or treatment that were not needed. The NCI adds that false positives can cause anxiety and that follow-up procedures carry risks of their own.
False negative
A negative result in someone who does have the condition. The test has missed it. The risk, as both the NHS and the NCI point out, is false reassurance: a person may ignore symptoms later because their last screen was clear.
Overdiagnosis
This is the hardest of the three to grasp, because the test is not wrong. The NCI, writing about cancer screening, describes overdiagnosis as finding a cancer that would never have caused symptoms or harm in the person’s lifetime. Treating it may not help the person live longer, and treatments have side effects. For an individual it is usually impossible to know whether a finding belongs in this group, which is why overdiagnosis shows up in statistics and not in a result letter.
The illustration shows why “being called back” is not a diagnosis. In this invented case most people who are called back do not have the condition, and yet the recall is how the five who do are found.
Reading your result
If the result is normal (sometimes worded “low chance” or “no further action”): the NHS explains that this means you are at low risk at present. It does not rule out the condition developing in future. If you notice symptoms, or something worries you between screens, speak to a doctor. Do not wait for the next invitation.
If you are asked back: this means the sieve has caught something worth a closer look. More tests are needed before anyone can say what it is. It is reasonable to ask how many people who are called back turn out to have the condition, and how long results usually take.
Why “survival” figures can mislead
Claims about screening often quote survival rates: the proportion of people alive a set number of years after diagnosis. The NCI explains why this can deceive. If screening moves the date of diagnosis earlier without changing when the person dies, survival measured from diagnosis looks longer although no life has been extended. This is called lead-time bias. Screening also tends to pick up slow-growing conditions, which have better outcomes anyway. For these reasons the NCI says the reliable evidence comes from randomised trials that compare death rates in screened and unscreened groups. When you see a number, check which kind it is, and look for absolute figures. Our explainer on relative and absolute risk shows how.
An informed choice
None of this is an argument against screening. Finding a problem early can make a real difference, and the limits described here are the reason programmes publish information and encourage questions. In the UK, the National Screening Committee says screening should always be a personal choice and that programmes should provide information to support it. The NCI likewise advises discussing the benefits and harms of a screening test with your doctor beforehand.
Family history, previous results and other personal factors can change what is advised, which is why a professional who knows your situation is the right person to ask. A short written list helps: see how to prepare for a medical appointment.
Sources
- UK National Screening Committee (GOV.UK) (UK) Population screening explained
- NHS (UK (England)) NHS screening
- National Cancer Institute (NIH) (US) Cancer Screening Overview (PDQ) – Patient Version
- National Cancer Institute (NIH) (US) Crunching Numbers: What Cancer Screening Statistics Really Tell Us
- World Health Organization Regional Office for Europe (International (WHO European Region)) Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm
How this guide was prepared
Written by Meetis Editorial with AI assistance, using the sources listed above, and checked against them before publication. It has not been reviewed by a doctor or other health professional. It is general information, not personal medical advice — for questions about your own health, speak to a qualified professional.
